期刊文献+

降调节与卵巢反应性 被引量:2

Down regulation and ovarian response
下载PDF
导出
摘要 Since COS in IVF creates the multiple follicle development which result in the rapid increase of E2 level and sensitivity to pituitary,reduce the bioactivity of GnSAF,bring about the premature LH surge occurren.It would harm the oocyte quality,which can be prevented by administration of GnRH-a.GnRH-a competes to occupy the receptor on pituitary.Thus,pituitary became desensitization clinically called as pituitary down regulation.It has been routinely used in COS for more than twenty years.However,the high dose of GnRH-a strongly inhibits the pituitary ovary axe,and led to the super suppress of ovarian response.The low dose of the GnRH-a or GnRHant has been recommended nowadays.Ovarian response is important for ART,so many indexes to evaluate the ovarian reserve.Some of them are available,such as age,FSH and AFC.For poor responder,the first experience of COS is the best evidence.Asymmetry follicle development and poor ovarian reserve are the most common in poor responder.The former can be adjusted by down regulation protocol and Gn dose administration,the later may take the oocyte donation into consideration. Since COS in IVF creates the multiple follicle development which result in the rapid increase of E2 level and sensitivity to pituitary, reduce the bioactivity of GnSAF, bring about the premature LH surge occurren. It would harm the oocyte quality, which can be prevented by administration of GnRH-a. GnRH-a competes to occupy the receptor on pituitary. Thus, pituitary became desensitization clinically called as pituitary down regulation. It has been routinely used in COS for more than twenty years. However, the high dose of GnRH-a strongly inhibits the pituitary ovary axe, and led to the super suppress of ovarian response. The low dose of the GnRH-a or GnRH-ant has been recommended nowadays. Ovarian response is important for ART, so many indexes to evaluate the ovarian reserve. Some of them are available, such as age, FSH and AFC. For poor responder, the first experience of COS is the best evidence. Asymmetry follicle development and poor ovarian reserve are the most common in poor responder. The former can be adjusted by down regulation protocol and Gn dose administration, the later may take the oocyte donation into consideration.
作者 庄广伦
出处 《生殖医学杂志》 CAS 2007年第5期297-298,共2页 Journal of Reproductive Medicine
关键词 降调节 卵巢反应性 卵巢储备 Down regulation Ovarian response Ovarian reserve
  • 相关文献

参考文献3

  • 1Karligiotou E,Kollia P,Kallitsaris A,et al.Expression of human serum albumin (HSA) mRNA in human granulosa cells:potential correlation of the 95 amino acid long carboxyl terminal of HSA to gonadotrophin surge-attenuating factor[J].Hum Reprod,2006,21(3):645-650.
  • 2Fanchin R,Cunha-Filho JS,Schonauer LM,et al.Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status[ J].Fertil Steril,2003,79 (3):585-589.
  • 3Inge GB,Brinsden PR,Elder KT.Oocyte number per live birth in IVF:were Steptoe and Edwards less wasteful[J]?Hum Reprod,2005,20(3):588-592.

同被引文献29

  • 1杨岫岩,朱旬,梁柳琴,詹钟平,叶玉津.环磷酰胺治疗系统性红斑狼疮导致卵巢功能衰竭的相关因素分析[J].中华医学杂志,2005,85(14):960-962. 被引量:26
  • 2邓波,章晓梅,任平,官洁,马艳萍,武泽.五种预测卵巢储备指标的临床研究[J].中国优生与遗传杂志,2006,14(4):102-104. 被引量:37
  • 3艾浩,牛建昭,薛晓鸥,王继峰,李健,李彧.化疗损伤性卵巢功能早衰小鼠动物模型的研究[J].中国实验动物学报,2007,15(1):35-38. 被引量:30
  • 4Roberto Angioli, Pierluigi Benedetti Panici, John J. Kavanagh. 妇科肿瘤的化疗--现今的治疗方法和新的治疗策略[M].向阳,冯凤芝.主译.北京:科学出版社,2007:342.
  • 5Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy [ J]. Curt Opin Obstet Gynecot, 2005,17 ( 1 ) :21-26.
  • 6Blumenfeld Z, Avivi I, Ritter M, et al. Preservation of fertility and ovarian function and minimizing chemotherapy - induced gonadotoxicity in young women[ J]. J Soc Gynecol Investig, 1999,6 (5) :229- 239.
  • 7Sonmezer M, Oktay K. Fertility preservation in female patients [ J ].Hum Reprod Update,2004,10 (3) :251-266.
  • 8Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group[ J]. Ann Oncol, 1990,1 (3) : 183-188.
  • 9Tangir J, Zelterrnan D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary[ J ]. Obstet Gynecol, 2003,101 (2) :251-257.
  • 10Fomier MN, Modi S, Panageas KS, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracyeline and taxane [ J ]. Cancer,2005,104 ( 8 ) : 1575-1579.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部